Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia (DG2)
Both index tests included in this guidance are no longer commercially available. Therefore the guidance has been withdrawn.
Both index tests included in this guidance are no longer commercially available. Therefore the guidance has been withdrawn.
This guideline has been updated and replaced by NICE guideline NG131.
This guidance has been updated and replaced by NICE diagnostics guidance 34.
This guidance has been updated and replaced by NICE diagnostics guidance 32.
This guidance has been updated and replaced by NICE diagnostics guidance 40.
In development [GID-DT9] Expected publication date: TBC
In development [GID-DT14] Expected publication date: TBC
In March 2019, NICE reviewed this guidance and recommended it should be withdrawn because Vision Amniotic Leak Detector is no longer available. NICE has produced a medtech innovation briefing on AmnioSense for unexplained vaginal wetness in pregnancy. For a copy of the review decision, please contact nice@nice.org.uk.
In development [GID-MT510] Expected publication date: TBC
In development [GID-MT517] Expected publication date: TBC
In March 2018, NICE reviewed this guidance and recommended it should be withdrawn as it has been updated and replaced by the NICE guideline on hypothermia: prevention and management in adults having surgery. For a copy of the review decision please contact nice@nice.org.uk.
In November 2016, NICE reviewed this guidance and recommended that it should be withdrawn. The guidance was published in June 2011 and recommended that further research was carried out on the technology. There was insufficient evidence on its use in clinical practice to recommend adoption. On reviewing the guidance in 2016, NICE determined that: The comparator in the original guidance, standard serial troponin testing, was changed in 2014 to high sensitivity troponin testing which expert advice indicated is now widespread in the NHS The clinical pathway in the original evaluation has significantly changed and the original scope is no longer valid. These changes mean that the current guidance is no longer valid and NICE would not be able to update it. The guidance has therefore been withdrawn. For a copy of the review decision please contact nice@nice.org.uk.
April 2020: This guidance has been withdrawn while the MHRA conducts an investigation into the MAGEC system. The MHRA issued a Medical Device Alert MDA/2020/011 for all MAGEC systems. This is in response to the manufacturer’s latest Field Safety Notice and previous field safety notices for problems that may require early removal of devices and lead to inadequate treatment. The MHRA is not recommending prophylactic removal of devices but the supply of all MAGEC systems is suspended in the UK while the MHRA investigation is ongoing. The MHRA has set out the following actions: Do not implant MAGEC rods in the UK until further notice. Identify all patients implanted with a MAGEC System and ensure systems are in place to follow up these patients.
In development [GID-MT536] Expected publication date: TBC
This medical technologies guidance has been replaced by the recommendation on cardiac output monitoring in the NICE guideline on perioperative care in adults.
In development [GID-MT516] Expected publication date: TBC
In development [GID-MT117] Expected publication date: TBC
In development [GID-MT130] Expected publication date: TBC
In development [GID-MT163] Expected publication date: TBC
In development [GID-MT267] Expected publication date: TBC
In development [GID-MT81] Expected publication date: TBC
This medical technologies guidance has been updated and replaced by NICE medical technologies guidance 53.
This guideline covered four common methods used to increase the population's physical activity levels: brief interventions in primary care, exercise referral schemes, pedometers and community-based walking and cycling programmes. It has been updated and replaced by the following NICE guidelines:
This guidance has been updated and replaced by NICE guideline NG60.
In development [GID-PHG58] Expected publication date: TBC
This guidance has been updated and replaced by NICE guideline NG92.
This guidance has been updated and replaced by NICE guideline NG64.
This guideline has been updated and replaced by NICE guideline NG90.
This guidance has been updated and replaced by NICE guideline NG44.
This guideline has been updated and replaced by NICE guideline PH52.
This guideline has been updated and replaced by NICE guideline NG146.
This guideline has been updated and replaced by NICE guideline NG135.
This guideline has been updated and replaced by NICE guideline NG92.
This guideline has been updated and replaced by NICE guideline NG60.
This guideline has been updated and replaced by NICE guideline NG33.
In development [GID-PHG59] Expected publication date: 24 March 2016
In development [GID-PHG0] Expected publication date: TBC
In development [GID-NG10053] Expected publication date: TBC